LumenAstra is commercializing a 麻豆免费版下载patent for a wearable, non-invasive sensor measuring core body temperature several centimeters below the skin with dramatic impact on cardiac surgery and聽brain protection after stroke and brain injury, increased efficacy of chemotherapy by targeted tumor warming, and a new generation of consumer thermometers. LumenAstra was awarded a non-dilutive $1 million聽NSF SBIR Phase II following their successful completion of the $256,000聽Phase I. One huge benefit for any seed investor is that for every $2聽invested, NSF will invest another $1. LumenAstra is also prequalified for the Colorado investment tax credit.
Funding Sought:聽$1 million Seed Round
For more information,聽contact聽Jim Pollock,聽jim@lumenastra.io